Who Makes Durvalumab
Durvalumab (Trade Name Imfinzi) Is an Fda-Approved Immunotherapy for Cancer, Developed by Medimmune/Astrazeneca. When Was Atezolizumab Approved by Fda? on...
Durvalumab (trade name Imfinzi) is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca.
When was atezolizumab approved by FDA?
On October 15, 2021, the Food and Drug Administration approved atezolizumab (Tecentriq, Genentech, Inc.)
Who makes Pembrolizumab?
Merck – the manufacturer of Keytruda (pembrolizumab) – is pulling the immunotherapy drug’s indication for patients with metastatic small cell lung cancer whose disease progressed on or after platinum-based chemotherapy and one or more prior line of therapy.
Robert Thorne covers electric vehicle innovations, autonomous driving systems, global mobility trends, and automotive engineering developments.
